glp-1 review article receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read glp 1 liver Current Status

This is the gap we need to acknowledge: we haven't built systems or cultures that make the basics easy to follow or easy to find

Information on this website is provided for product identification and laboratory research purposes only

On January 6, 2025, the Department of Justice announced that Athira Pharma agreed to pay $4,068,698 to settle False Claims Act allegations

Other loci, such as glucokinase regulator (GCKR) and membrane bound O-acyltransferase domain-containing 7 (MBOAT7), influence glucose metabolism, phospholipid remodeling, and insulin sensitivity, highlighting the tight link between metabolic dysfunction and liver injury